• Monday, March 27, 2017

    cloudvirga Raises $15M More For Mortgage Automation Tools

    Irvine-based Cloudvirga, a developer of automated mortgage lending software, announced this morning that it has raised $15M more in a Series B funding. The funding was led by Incenter, a Blackstone Group portfolio company. The company said the funding goes to scale its technology and product offerings. The company has now raised $22.5M in total. Cloudvirga was founded by Bill Dallas, Kyle Kamrooz and Mark Attaway....More →

  • Monday, March 27, 2017

    The Virtual Reality Company Debuts New VR Series For Families

    Los Angeles The Virtual Reality Company said this morning that it has released a new, animated virtual reality (VR) series, called Raising a Rukus. The company said it is the first to debut a series of the kind specifically for families. The Virtual Reality Company (VRC) previously had released the virtual reality series, The Martian VR for Twentieth Century Fox. The company said Raising a Rukus revolves are "magical adventures" with a brother and sister led by their mischievous pet dog, Rukus....More →

  • Monday, March 27, 2017

    Alteryx Sees Solid IPO Debut

    Irvine-based data analytics software developer Alteryx had its IPO debut on Friday, debuting at $14.00 per share on the NYSE as AYX, and closing out the day at $15.50 per share. The company rose 10.71 percent in its IPO debut on the public markets. The public offering raised $126M for the company. Alteryx was venture backed by Insight Venture Partners, Sapphire Ventures, Thomson Reuters, Toba Capital, and ICONIQ Capital.More →

  • Monday, March 27, 2017

    Sienna Biopharmaceuticals Names CFO

    Westlake Village-based Sienna Biopharmaceuticals said Friday that it has named Richard Peterson as the company's new Chief Financial Officer. Peterson was most recent at Novan, where he also served as Chief Financial Officer, and also has served as CFO and Treasurer at Medicis Pharmaceutical Corporation, in addition to serving as an auditor at PricewaterhouseCoopers. Sienna says that Peterson will take over from John Smither, who is retiring, but will remain as an advisor....More →

  • Monday, March 27, 2017

    HyperX Debuts New DDR4 Gaming Memory

    Fountain Valley-based HyperX, the divisio of Kingston Technology Company which focuses on the high performance gaming market, announced a new DDR4 memory product today called the HyperX FURY. The new DDR4 memory is designed specifically for the gaming market, with support for "overclocked" gaming PCs up to 2666MHz, available in three different colors (black, red, and white), and support for the Intel 200 series processors and X99 chipsets plus AMD's Ryzen processors....More →

  • Friday, March 24, 2017

    Cool Planet Reboots, In Colorado, With $19.3M Series A Funding

    Cool Planet, the former Camarillo, California startup working on carbon conversion technology, has resurfaced in Colorado with a $19.3M Series A funding. According to Cool Planet, the new funding was led by Agustín Coppel and North Bridge Venture Partners, and will go towards commercalization of its biochar product, Cool Fauna Engineered Biocarbon....More →

  • Friday, March 24, 2017

    Alteryx Prices IPO, To Debut On NYSE Today

    Irvine-based Alteryx priced its IPO on Thursday evening, saing that it will sell 9,000,000 shares of its Class A common stock at $14.00 per share. Alteryx will begin trading this morning as AYX on the New York Stock Exchange. The company, which develops data analytics software, priced at the high end of its estimated initial IPO range, which had been between $12.00 and $14.00 per share....More →

  • Friday, March 24, 2017

    SpaceX Aims At Re-Launching Rocket With Next Mission

    Hawthorne-based SpaceX is getting set to launch its first, ever, reusable rocket stage next week, in what could be a historic moment for spaceflight. SpaceX reportedly will use the same Falcon 9 first stage booster it used for the earlier CRS-8 mission, for the launch of the SES-10 satellite. The launch is expected to occur as soon as March 29th....More →

  • Friday, March 24, 2017

    Shift Launches Online Car Buying, Selling Service In San Diego

    Shift, an online car buying and selling startup based in San Francisco, said on Thursday that it has launched buyer operations in San Diego, allowing people to buy and sell cars in the market. The startup is backed by more than $73M in funding from DFJ, Highland Capital, and Goldman Sachs Investment Partners. Shift's service manages the entire buying and selling process, and includes on-demand test drives, on-site appraisals, and pickup of automobiles, and even handles DMV paperwork....More →

  • Friday, March 24, 2017

    Western Digital Backs Avere Systems

    Irvine-based storage device maker Western Digital has backed Avere Systems, a developer of a file system for the hybrid cloud. Avere said this week that it has raised $14M in a Series E funding round, which came from Menlo Ventures, Norwest Venture Partners, Lightspeed Venture Partners, Tenaya Capital and Western Digital Capital, along with Google. Western Digital Capital, the venture capital arm of Western Digital, was an existing investor in Avere....More →

  • Friday, March 24, 2017

    Qualcomm, AT&T, CH2M In Water Management Effort

    San Diego-based Qualcomm Intellignt Solutions, a subsidiary of Qualcomm Incorporated, has linked up with AT&T and CH2M to use Qualcomm's modem technology to monitor water usage in Georgia the company said on Thursday. Qualcomm said its power-efficient modems are being used to monitor non-revenue water usage for the Gwinnett County Department of Water Resources (Gwinnett County) in Georgia. Financial impact of the win was not announced....More →

  • Thursday, March 23, 2017

    Ignyta Seeks To Sell Off Development Program

    San Diego-based biopharmaceuticals developer Ignyta said on Thursday afternoon that it is looking to sell of its taladegib oncology program, after reaching a deal to change licensing terms it has with Eli Lilly and Company. Ignyta said it is "exploring strategic options" for taladegib, as it shifts it focus to its molecular therapy program, entrectinib. Taladegib is aimed at potentially treating a number of rare cancers. Ignyta did not say how much it is looking to sell the program for....More →

More Headlines »
View Site in Mobile | Classic

Keep up with all of the latest Southern California high tech news via email (it's free!)

or Cancel